Page 57 - Merck Sharp News Today

Spanish anitrust agency Comisión Nacional de los Mercados y la Compentencia (CNMC) Tuesday fined US pharmaceutical company Merck Sharp and Dohme (MSD) 39 million euros for abuse of the market. The age...

For women who do not wish to become pregnant, contraceptive use after breast cancer diagnosis and treatment should be a priority, especially given restrictive access to abortions in many states.

A suit was filed on Monday in the District of Delaware by Merck Sharp & Dohme LLC against Prinston Pharmaceutical Inc. The complaint alleges that

/PRNewswire/ -- The Insight Partners published latest research study on "Diabetes Therapeutics Market Size, Share, Revenue, Growth Strategy, Industry Trends...

In Mylan Pharm. Inc. v. Merck Sharp & Dohme Corp., the Federal Circuit considered whether prior disclosure of a genus of compounds and their pharmaceutically acceptable salts was...

HELSINKI--(BUSINESS WIRE)--TILT Biotherapeutics, a clinical-stage biotechnology company developing cancer immunotherapies, announces that the first US patient has been dosed in its ovarian cancer trial (NCT05271318), using its oncolytic adenovirus, TILT-123, that has the potential to be first-in-class for this indic...

This study estimates the proportion of males and females, younger or older than 20 years of age, affected by at least 1 of the 3 Long COVID symptom clusters (pe

Combination treatment with the GX-188E vaccine and pembrolizumab can elicit responses in patients with HPV 16-/18-positive advanced cervical cancer.

Relationship is particularly high within 1 month of type 1 diabetes onset, suggesting potential preventive role for vaccination or antivirals.

/PRNewswire/ -- The "PD-1/PDL-1 Inhibitor Market - A Global and Regional Analysis: Focus on Epidemiology, Product, and Region - Analysis and Forecast,...